These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3791354)

  • 21. Effects of dantrolene sodium on occlusion and reperfusion arrhythmias in the canine heart.
    Pelleg A; Roth A; Shargordsky B; Belhassen B; Chagnac A; Laniado S
    Methods Find Exp Clin Pharmacol; 1985 May; 7(5):239-43. PubMed ID: 4033300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemodynamic and metabolic effects of the antiarrhythmic drug melperone during acute left ventricular failure in dogs.
    Smiseth OA; Platou ES; Refsum H; Mjøs OD
    Cardiovasc Res; 1981 Dec; 15(12):724-30. PubMed ID: 7326689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiapamil in the management of supraventricular arrhythmias occurring after acute myocardial infarction.
    Strozzi C; Sfrisi C; Leutenegger F; Padula A; Bulgarelli R
    Cardiology; 1982; 69 Suppl():187-91. PubMed ID: 7151079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of tiapamil on perioperative cardiac arrhythmias and myocardial function.
    List WF; Metzler H
    Cardiology; 1982; 69 Suppl():157-64. PubMed ID: 6185222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic effects of the thromboxane antagonist BM 13.177.
    Wainwright CL; Parratt JR
    Eur J Pharmacol; 1987 Jan; 133(3):257-64. PubMed ID: 3104065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nifedipine reduces arrhythmias but does not alter prostanoid release during coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1983; 5(3):406-17. PubMed ID: 6191139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effects of haemodynamic stabilisation and beta blockade on ventricular fibrillation threshold in coronary artery ligated pigs.
    Muller CA; Kralios AC
    Cardiovasc Res; 1993 Feb; 27(2):274-8. PubMed ID: 8097133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate.
    Barros LF; Da-Luz PL; Silveira MC; Chagas AC; Pileggi F
    Braz J Med Biol Res; 1988; 21(4):791-9. PubMed ID: 3240378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tiapamil on haemodynamics and myocardial salvage during myocardial infarction in the baboon.
    Rogers GG; Rosendorff C; Shimell CJ; Coull A
    Cardiology; 1982; 69 Suppl():58-67. PubMed ID: 7151084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic action and protection of ischaemia myocardium after beta-blockade with bevantolol.
    Verdouw PD; Van Bremen RH; Verkeste CM; Van der Giessen WJ
    Eur J Pharmacol; 1985 May; 111(3):377-80. PubMed ID: 2862050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of flecainide on occlusion and reperfusion arrhythmias in dogs.
    Lederman SN; Wenger TL; Bolster DE; Strauss HC
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):541-6. PubMed ID: 2470990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial M-mode echocardiography in evaluation of the cardiovascular effects of tiapamil and their relationship to plasma levels in patients with coronary heart disease.
    Lindvall K; Cocco G; Wendt G; Chu D; Heizmann P
    Int J Cardiol; 1981; 1(1):15-24. PubMed ID: 7333712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic and antifibrillatory properties of McN-4130 in several animal models.
    Damiano BP; Sit SP; Fortunato MA; Stranieri MT; Brannan MD
    J Cardiovasc Pharmacol; 1988 May; 11(5):581-90. PubMed ID: 2455845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion.
    Brooks WW; Verrier RL; Lown B
    Cardiovasc Res; 1980 May; 14(5):295-302. PubMed ID: 7388861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of carbocromene on ventricular fibrillation during acute myocardial ischemia in anesthetized dogs.
    Fiedler VB; Schneider S; Nitz RE
    Pharmacology; 1982; 25(2):96-101. PubMed ID: 7134263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.
    Naito M; Michelson EL; Kmetzo JJ; Kaplinsky E; Dreifus LS
    Circulation; 1981 Jan; 63(1):70-9. PubMed ID: 7438409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
    Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
    Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of the new calcium antagonist benidipine hydrochloride on myocardial dysfunction following coronary occlusion and reperfusion in anesthetized dogs.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1717-21. PubMed ID: 3219147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and hemodynamic effects of tiapamil: exercise performance, thallium stress scintigraphy, and radionuclide ventriculography.
    Eckert M; Pozenel H; Pillat B
    J Clin Pharmacol; 1984 Apr; 24(4):165-73. PubMed ID: 6725618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.